BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29886242)

  • 21. Recent developments on the vascular effects of 20-hydroxyeicosatetraenoic acid.
    Garcia V; Schwartzman ML
    Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):74-82. PubMed ID: 27906746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 20-hydroxyeicosatetraenoic acid, endothelial dysfunction and hypertension.
    Pat Kunert M; Drenjancević I
    Med Glas (Zenica); 2011 Aug; 8(2):170-80. PubMed ID: 21849935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR.
    Savas Ü; Wei S; Hsu MH; Falck JR; Guengerich FP; Capdevila JH; Johnson EF
    J Biol Chem; 2016 Aug; 291(32):16904-19. PubMed ID: 27298316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease.
    Minuz P; Jiang H; Fava C; Turolo L; Tacconelli S; Ricci M; Patrignani P; Morganti A; Lechi A; McGiff JC
    Hypertension; 2008 May; 51(5):1379-85. PubMed ID: 18378855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage.
    Mennuni S; Rubattu S; Pierelli G; Tocci G; Fofi C; Volpe M
    J Hum Hypertens; 2014 Feb; 28(2):74-9. PubMed ID: 23803592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
    Imig JD
    Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids.
    Roman RJ; Maier KG; Sun CW; Harder DR; Alonso-Galicia M
    Clin Exp Pharmacol Physiol; 2000 Nov; 27(11):855-65. PubMed ID: 11071299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.
    Wu CC; Mei S; Cheng J; Ding Y; Weidenhammer A; Garcia V; Zhang F; Gotlinger K; Manthati VL; Falck JR; Capdevila JH; Schwartzman ML
    J Am Soc Nephrol; 2013 Jul; 24(8):1288-96. PubMed ID: 23641057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy.
    Gangadhariah MH; Luther JM; Garcia V; Paueksakon P; Zhang MZ; Hayward SW; Love HD; Falck JR; Manthati VL; Imig JD; Schwartzman ML; Zent R; Capdevila JH; Pozzi A
    J Am Soc Nephrol; 2015 Mar; 26(3):597-610. PubMed ID: 25071086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 20-Hydroxyeicosatetraenoic acid (20-HETE): Bioactions, receptors, vascular function, cardiometabolic disease and beyond.
    Pascale JV; Wolf A; Kadish Y; Diegisser D; Kulaprathazhe MM; Yemane D; Ali S; Kim N; Baruch DE; Yahaya MAF; Dirice E; Adebesin AM; Falck JR; Schwartzman ML; Garcia V
    Adv Pharmacol; 2023; 97():229-255. PubMed ID: 37236760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450 arachidonic acid omega-hydroxylation in the proximal tubule of the rat kidney.
    Lin F; Abraham NG; Schwartzman ML
    Ann N Y Acad Sci; 1994 Nov; 744():11-24. PubMed ID: 7529972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-κB Translocation and Promoter Binding.
    Garcia V; Shkolnik B; Milhau L; Falck JR; Schwartzman ML
    J Pharmacol Exp Ther; 2016 Mar; 356(3):525-33. PubMed ID: 26699146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Antihypertensive Effect of Quercetin in Young Spontaneously Hypertensive Rats; Role of Arachidonic Acid Metabolism.
    Elbarbry F; Abdelkawy K; Moshirian N; Abdel-Megied AM
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome P450 eicosanoids in hypertension and renal disease.
    Fan F; Muroya Y; Roman RJ
    Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):37-46. PubMed ID: 25427230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiological role of 20-HETE a cytochrome P450 metabolite of arachidonic acid.
    Kamata K
    J Pharmacol Sci; 2005 Feb; 97(2):303-4. PubMed ID: 15725698
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat.
    Schwartzman ML; da Silva JL; Lin F; Nishimura M; Abraham NG
    Nephron; 1996; 73(4):652-63. PubMed ID: 8856265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current.
    Gebremedhin D; Lange AR; Narayanan J; Aebly MR; Jacobs ER; Harder DR
    J Physiol; 1998 Mar; 507 ( Pt 3)(Pt 3):771-81. PubMed ID: 9508838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE.
    Inoue K; Sodhi K; Puri N; Gotlinger KH; Cao J; Rezzani R; Falck JR; Abraham NG; Laniado-Schwartzman M
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F875-84. PubMed ID: 19675180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conflicting Roles of 20-HETE in Hypertension and Stroke.
    Shekhar S; Varghese K; Li M; Fan L; Booz GW; Roman RJ; Fan F
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrarenal Angiotensin-Converting Enzyme: the Old and the New.
    Culver S; Li C; Siragy HM
    Curr Hypertens Rep; 2017 Sep; 19(10):80. PubMed ID: 28929450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.